Collectively, accumulating evidence implicates that eNMDAR activation and imbalanced sNMDAR/eNMDAR activity tone are possible causal factors acting upstream of late-onset AD pathophysiology, including Aβ and tau pathology (Figs. 4 and 5). This evidence concerns the gene MAPT and Alzheimer disease.